The ROE (Return on Equity) of Genomic Vision SA (GV.PA) is 526.76%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2022-12-31 | 526.76% |
| 2021-12-31 | -162.80% |
| 2020-12-31 | -165.77% |
| 2019-12-31 | -142.80% |
| 2018-12-31 | -165.54% |
| 2017-12-31 | -241.44% |
| 2016-12-31 | -85.83% |
| 2015-12-31 | -23.60% |
| 2014-12-31 | -9.50% |
| 2013-12-31 | -109.18% |